PT
BIIB icon

Plimoth Trust’s Biogen BIIB Stock Holding History

Plimoth Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,010
Closed -$282K – 165
2021
Q1 		$282K Buy
1,010
+3
+0.3% +$809 0.08% 153
2020
Q4 		$246K Sell
1,007
-332
-25% -$85.6K 0.08% 149
2020
Q3 		$380K Sell
1,339
-105
-7% -$29.3K 0.13% 131
2020
Q2 		$386K Sell
1,444
-495
-26% -$149K 0.14% 131
2020
Q1 		$614K Sell
1,939
-405
-17% -$123K 0.26% 106
2019
Q4 		$695K Sell
2,344
-1,585
-40% -$440K 0.22% 125
2019
Q3 		$915K Sell
3,929
-1,797
-31% -$418K 0.3% 99
2019
Q2 		$1.34M Sell
5,726
-1,532
-21% -$354K 0.44% 74
2019
Q1 		$1.72M Sell
7,258
-90
-1% -$28.3K 0.57% 60
2018
Q4 		$2.21M Sell
7,348
-75
-1% -$23.9K 0.82% 35
2018
Q3 		$2.62M Sell
7,423
-625
-8% -$215K 0.85% 34
2018
Q2 		$2.34M Buy
8,048
+535
+7% +$150K 0.8% 40
2018
Q1 		$2.06M Buy
7,513
+850
+13% +$264K 0.71% 44
2017
Q4 		$2.12M Buy
+6,663
New +$2.14M 0.76% 39

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Plimoth Trust's BIIB Position: Q2 2021 in Review

Plimoth Trust sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,010 shares — an estimated $282K sold.

Plimoth Trust first reported a position in BIIB in Q4 2017 and held it in 14 quarters. The position peaked at $2.62M in Q3 2018. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Plimoth Trust reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Plimoth Trust sold 1,010 Biogen shares in Q2 2021, an estimated $282K.
  • Plimoth Trust first reported a position in Biogen in Q4 2017 and held it in 14 quarters.
  • Plimoth Trust's Biogen position peaked at $2.62M in Q3 2018.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Plimoth Trust's 13F filing for Q2 2021, filed 20 Jul 2021.